3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Lymphoma, Non-Hodgkin
5
Lymphoma, Large B-Cell, Diffuse
4
Recurrence
3
Myeloproliferative Disorders
3
Lymphoma
3
Primary Myelofibrosis
2
Lymphoma, Follicular
2
Lymphoma, B-Cell, Marginal Zone
2
Lymphoma, T-Cell, Peripheral
1
Lymphoma, Mantle-Cell
1
Lymphoma, B-Cell
1
Leukemia, Lymphocytic, Chronic, B-Cell
1
Leukemia
1
Interventions
Cyclophosphamide
9
mogamulizumab
6
Biopsy
6
fludarabine
5
fludarabine phosphate
4
Specimen Handling
4
Immunoglobulin G
4
Disulfides
4
Brentuximab Vedotin
4
ruxolitinib
3
romidepsin
3
pembrolizumab
3
Peripheral Blood Stem Cell Transplantation
3
Mycophenolic Acid
3
Magnetic Resonance Spectroscopy
3
Lenalidomide
3
Etoposide
3
Busulfan
3
hypericin
2
Whole-Body Irradiation
2
Vincristine
2
Tacrolimus
2
Prednisone
2
Nivolumab
2
Melphalan
2
Depsipeptides
2
Bexarotene
2
tofacitinib
1
thymoglobulin
1
tazemetostat
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma, T-Cell, Cutaneous
×
parsaclisib
×
1 year
×
Clear all
No trials found.